This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
G vs. EXLS: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. EXLS: Which Stock Is the Better Value Option?
5 Top-Ranked Value Stocks With Discounted PEG Ratio to Buy
by Urmimala Biswas
Five PEG-based stocks that fulfill our screening criteria are Genpact, MPLX, Exelixis, Paramount Global and H&R Block.
Why You Should Retain Corpay Stock in Your Portfolio Now
by Zacks Equity Research
CPAY has been consistently pursuing acquisitions and investments to increase its customer base, workforce and operational capabilities.
Genpact (G) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Reasons Why You Should Hold Rollins (ROL) Stock Now
by Zacks Equity Research
Rollins (ROL) has a track record of consistent dividend payments.
Here's Why H&R Block (HRB) Stock is a Great Pick Right Now
by Zacks Equity Research
The main drivers of H&R Block's (HRB) post-pandemic performance are digital enablement of business, client addition and retention, and greater usage of AI.
Reasons Why You Should Bet on Charles River (CRAI) Stock Now
by Zacks Equity Research
Commitment to shareholder returns makes Charles River (CRAI) a reliable way for investors to compound wealth over the long term.
CEB Acquisition Benefits Gartner (IT) Amid Tough Competition
by Zacks Equity Research
Gartner (IT) is gaining from its ability to provide insights using data collected by advanced technologies.
Is First Trust Industrials/Producer Durables AlphaDEX ETF (FXR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXR
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.
Is Genpact (G) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Genpact Limited (G) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Genpact (G) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Genpact's (G) Q2 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Genpact's (G) second-quarter 2024 earnings and revenues increase on a year-over-year basis.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include Ingredion, YETI, Dutch Bros, Heritage Insurance and Genpact
by Zacks Equity Research
Ingredion, YETI, Dutch Bros, Heritage Insurance and Genpact are part of the Zacks Screen of the Week article.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Stocks With Upgraded Broker Ratings to Bet on Right Now
by Swayta Shah
Brokers have deeper insights into stocks and macroeconomic factors. So, one must follow broker rating upgrades to pick stocks like Ingredion (INGR), YETI Holdings (YETI), Dutch Bros (BROS), Heritage Insurance (HRTG) & Genpact (G).
G or ADP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
G vs. ADP: Which Stock Is the Better Value Option?
Genpact (G) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 8.22% and 2.64%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Brink's (BCO) Tops Q2 Earnings Estimates
by Zacks Equity Research
Brink's (BCO) delivered earnings and revenue surprises of 17.61% and 0.02%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Automatic Data Processing (ADP) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
ADP (ADP) delivered earnings and revenue surprises of 0.97% and 0.71%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
TriNet Group (TNET) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
TriNet (TNET) delivered earnings and revenue surprises of 23.39% and 2.73%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Genpact (G) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
G vs. PAYX: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Here's Why Genpact (G) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.